Efficacy and Safety of TAK-583 in Subjects With Diabetic Peripheral Neuropathy

NCT00760955 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

338

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathies

Interventions

DRUG: TAK-583
DRUG: TAK-583
DRUG: TAK-583
DRUG: Placebo

Sponsor

Takeda